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The fatty acid ethanolamides (FAEs) are lipid media-
tors present in all organisms and involved in highly
conserved biological functions, such as innate im-
munity, energy balance, and stress control. They
are produced from membrane N-acylphosphatidyle-
thanolamines (NAPEs) and include agonists for G
protein-coupled receptors (e.g., cannabinoid recep-
tors) and nuclear receptors (e.g., PPAR-a). Here, we
report the crystal structure of human NAPE-hydro-
lyzing phospholipase D (NAPE-PLD) at 2.65 A˚
resolution, a membrane enzyme that catalyzes FAE
formation in mammals. NAPE-PLD forms homo-
dimers partly separated by an internal 9-A˚-wide
channel and uniquely adapted to associate with
phospholipids. A hydrophobic cavity provides an
entryway for NAPE into the active site, where a binu-
clear Zn2+ center orchestrates its hydrolysis. Bile
acids bind with high affinity to selective pockets in
this cavity, enhancing dimer assembly and enabling
catalysis. These elements offer multiple targets for
the design of small-molecule NAPE-PLD modulators
with potential applications in inflammation andmeta-
bolic disorders.
INTRODUCTION
The fatty acid ethanolamides (FAEs) are a family of bioactive
lipids with conserved cellular signaling functions throughout
phylogeny (Chapman, 2004; Kang et al., 2008; Lucanic et al.,
2011; Wellner et al., 2013). In mammals, monounsaturated and
saturated FAEs (e.g., oleoylethanolamide and palmitoylethano-
lamide) are agonists for peroxisome proliferator-activated nu-
clear receptors (PPAR-a) (Fu et al., 2003) and G protein-coupled
receptors (GPCRs) (GPR119 and GPR55) (Godlewski et al.,
2009). Oleylethanolamide regulates satiety, body weight, and
cancer cell proliferation (Piomelli, 2013; Masoodi et al., 2014);
palmitoylethanolamide serves as an early stop signal, which
contrasts the progress of inflammation (Solorzano et al., 2009).598 Structure 23, 598–604, March 3, 2015 ª2015 Elsevier Ltd All righOn the other hand, polyunsaturated FAEs (e.g., anandamide)
activate cannabinoid receptors (CBs) (the sameGPCRs targeted
by the psychotropic component D9-tetrahydrocannabinol in
marijuana) and contribute in important ways to the regulation
of food intake, stress and pain response, and synaptic function
(Kathuria et al., 2003; Hohmann et al., 2005; Di Marzo and Mat-
ias, 2005; Di Marzo, 2008; Piomelli and Sasso, 2014). Despite the
relevant signaling roles of these lipid molecules, little is known
about the physiological stimuli that lead to their production or
about the mechanism and regulation of their biogenesis.
The first step in mammalian FAE biosynthesis is the transfer of
a fatty acyl group from the sn-1 position of phosphatidylcholine
to the amine of phosphatidylethanolamine (PE) (Schmid et al.,
1996). This process produces a family of NAPEs, which are un-
usual among glycerophospholipids in that they contain three
fatty acyl chains embedded in the lipid bilayer (Lafrance et al.,
1997). A membrane-associated phospholipase, NAPE-PLD,
cleaves the distal phosphodiester bond of NAPEs to generate
bioactive FAEs and phosphatidic acid (PA) (Okamoto et al.,
2004). The sequence of the NAPEPLD gene predicts a member
of the metallo-b-lactamases (MbLs) (Wang et al., 2006), a protein
superfamily that includes hydrolases involved in antibiotic resis-
tance, DNA repair, and RNA maturation (Garau et al., 2005;
Dominski, 2007). NAPE-PLD is unrelated to other mammalian
phospholipases D (PLD1 and PLD2) (Stuckey and Dixon, 1999)
and further differs from these enzymes in its ability to selectively
hydrolyze NAPEs (Okamoto et al., 2004). Importantly, NAPE-
PLD recognizes all NAPEs, irrespective of their N-acyl substitu-
ents (Wang et al., 2006), and is able therefore to produce FAEs
with diverse biological activities. To understand the molecular
bases of FAE biosynthesis, we have determined the structure
of human membrane NAPE-PLD at a resolution of 2.65 A˚
(Table 1), crystallized in the presence of the detergent sodium
deoxycholate (DC). Our findings reveal unexpected binding sites
and a potential key role of this natural bile acid in enzyme
regulation.
RESULTS
Structure of Human NAPE-PLD and its Membrane
Association
NAPE-PLD was crystallized in lithium sulfate by adding the bile
acid DC (0.09%) to the purified protein (see Experimentalts reserved
Table 1. Data Collection and Refinement Statistics
NAPE-PLD
Data Collection native selenomethionine
Synchrotron, beamline ELETTRA, XRD1 ESRF, ID23h2
Wavelength (A˚) 0.9795 0.8729
Space group P6522 P6522
Cell dimensions
a, b, c (A˚) 95.10, 95.10, 444.17 95.19, 95.19, 444.27
a, b, g () 90, 90, 120 90, 90, 120
Resolution (A˚) 88.83–2.65
(2.72–2.65)
55.53–3.20
(3.42–3.20)
Rsym 0.05 (0.55) 0.16 (0.56)
I/sI 26.7 (3.8) 22.6 (9.3)
Completeness (%) 100.0 (99.9) 100.0 (100.0)
Redundancy 14.1 (12.3) 41.2 (42.9)
Resolution (A˚) 82.36–2.65
(2.72–2.65)
55.53–3.20
(3.42–3.20)
No. unique reflections 34,047 20,932
SAD phasing
No. molecules in
asymmetric units
2
No. of Se sites 16
Solvent content 0.63
FOMa 0.404
Refinement Statistics
Rwork/Rfree
b 0.214 (0.334)/
0.253 (0.331)
No. of atoms 5875
Protein 5361
Zinc 4 3 1
PE 2 3 44
DC 7 3 28
Sulfate 3 3 5
Water 100
B factors (A˚2) 76.0
Protein 77.2
Zinc 62.2
PE 70.1
DC 70.3
Sulfate 60.4
Water 59.3
Root-mean-square deviations
Bond lengths (A˚) 0.014
Bond angles () 2.38
Ramachandran plotc
Preferred (%) 88.0
Allowed (%) 7.1
Outliers (%) 4.9
The numbers in parentheses are for the highest resolution shell.
aFigure of Merit (experimental phases) = hjPPðaÞexpðiaÞ=PPðaÞji,
where a is the phase and P(a) is the phase probability distribution.
bThe Rfree was calculated with a random 5% of the reflections.
cValues from Molprobity (http://molprobity.biochem.duke.edu).
Structure 23,Procedures). The crystal structure was solved by the method of
single-wavelength anomalous diffraction (SAD) with phase infor-
mation derived from the anomalous scattering of 16 selenium
atoms in the asymmetric unit (Table 1; see also Experimental
Procedures). The enzyme forms a dimer with two interconnected
protein subunits, partially separated by an internal channel (Fig-
ure 1). Each subunit contains the four-layered abba core typical
of the MbL superfamily (Carfi et al., 1995; De la Sierra-Gallay
et al., 2005); however, various structural elements distinguish
NAPE-PLD from other MbL proteins and allow this enzyme to
interact with membrane phospholipids. These elements include
an elongated N-terminal helix a0 and loop L0 (Figure 1A; Fig-
ure S1A available online), which replace the b1 strand present
in most MbL proteins, and a second extended loop (L1), which
substitutes for the MbL a1 helix (Figures 1A and S1A). The L0
and L1 loops are rigidified by a high frequency of proline residues
(12.7% from P68 to P177, compared with 6.6% and 6.2% in
NAPE-PLD and human proteome, respectively) (Figure S1A)
(Morgan and Rubenstein, 2013), and mediate most intersubunit
interactions (Figure 1A). Together with helices ao and a2, L0
and L1 form at the dimer interface an internal channel with a
diameter of 9 A˚ (Figure 1B).
A positive electrostatic potential prevails at the subunit inter-
face of the NAPE-PLD dimer (Figure S1B). It is mainly due to
several charged residues (K97, K108, R164, R166, R167,
K202) that are exposed by both subunits within the internal chan-
nel. The presence of the channel and electrostatic repulsion
among these residues limits the contact between the two sub-
units to an area (surface interaction area, ISA/2z1010 A˚2) that
is substantially smaller than those generally found in obligate
homodimeric proteins (z1940 A˚2) (Bahadur et al., 2003). The
area involves the L1 loop and a series of intersubunit H bonds
(residues R153‒N194, S157‒Q158, Q158‒N194, Y159‒Y193,
and K163‒E201) (Figures 1A and S1A). To probe the function
of this unusual molecular architecture, we generated a NAPE-
PLD in which Q158 and Y159 (Figures 1A and S1A) are replaced
by serines. We found that this loop L1-directed double mutation
(which does not affect the overall MbL fold and residue polarity of
NAPE-PLDmonomers [Figure 1A]) disrupts the subunits ability to
dimerize (Figure S1C) and hydrolyze NAPE (see below). These
findings suggest a critical role for the L1 loop in dimer assembly
and catalysis (Figure 1A).
In agreement with its expected membrane association, cryoe-
lectron microscopy studies show that NAPE-PLD is found
mainly in the proximity of cellular membranes (Figure S2). This
is consistent with the presence in the structure of an extended
hydrophobic surface that spans both protein dimer subunits
and includes residues of the N terminus, loop L1, helix a3, and
loop L3 (Figure 1). At the membrane interface, the NAPE-PLD
dimer forms a hydrophobic nook that contains two molecules
of PE, one bound to each monomer (Figure 1B). This phospho-
lipid constitutes 75–80 mol % of the cell membranes of
Escherichia coli (Morein et al., 1996), which was used to pro-
duce the recombinant protein for crystallization. PE is not a
substrate for NAPE-PLD, but its structural similarity with NAPE
suggests that it occupies a portion of the site reserved for
this molecule (Figure 2A). Consistent with this view, PE
inhibits detergent-stimulated NAPE-PLD activity with an IC50
of z30 mM (Figure S3A).598–604, March 3, 2015 ª2015 Elsevier Ltd All rights reserved 599
Figure 1. Structure of Human NAPE-PLD
(A) Ribbon trace of the NAPE-PLD dimer, front view (top) and bottom view (bottom). Dimer subunits interact mainly through their loops L0 (magenta) and L1 (blue),
structural elements that distinguishes NAPE-PLD from other MbL proteins. The subunit orientation produces a symmetric alignment of loops L1, which extend in
the dimer the existingmonomer binding faces. The active sites contain a binuclear zincmetal center (spheres, color cyan), which faces the lipid bilayer and binds a
molecule of PE (carbon atoms in orange). PE derives from the expression system used to produce NAPE-PLD and occupies the binding site reserved for the PE
fragment of NAPE. Several molecules of the nonconjugated C24 bile acid DC (carbon atoms in green) bind to the enzyme, creating a lipid substructure at the
interface with the membrane. N and C indicate the N terminus and C terminus of the protein, respectively. The asterisks indicate the position of L1 residues Q158
and Y159.
(B) Surface representation of the NAPE-PLD dimer shown with the same orientation as in (A). An internal channel with a diameter of9 A˚ partly separates the two
subunits of NAPE-PLD and overlooks a hydrophobic nook to which PE and DC are bound. The predicted membrane boundary is shown as a dotted line.A Binuclear Zinc Center Orchestrates NAPE Hydrolysis
In the proximity of the polar head of PE, an electron density map
shows the presence of two metal ions, which bind the PE phos-
phate group in a trigonal bipyramidal geometry (Figure 2A). The
metal center of NAPE-PLD contains zinc, as revealed by X-ray
fluorescence analyses (Figure S3B). The L1 loop provides most
of the hydrophobic surface involved in the binding of the sn-1
chain of PE, while the L3 loop binds the sn-2 chain and stretches
out into the membrane interface (Figure 2A). The arrangement of
L1, L3, and helix a3 shapes a broadening of the hydrophobic
nook, in which the N-acyl chain of NAPE can be accommodated
(Figure 2A). This provides both an entry point for NAPE into the
active site and a membrane exit path for products of NAPE hy-
drolysis. Moreover, the width of this cavity may explain the ability
of NAPE-PLD to recognize NAPE species with diverse N-acyl
substituents. Residues H185–D189, which are part of the L2
loop, coordinate the substrate-bound binuclear metal center,
while H321 forms a hydrogen bond with the ethanolamine oxy-
gen of PE (Figure 2A). An adjacent glutamine residue, Q320, is
ideally positioned to form a hydrogen bridge with the carboxa-600 Structure 23, 598–604, March 3, 2015 ª2015 Elsevier Ltd All righmide oxygen of NAPE (Figure 2A). These interactions may help
the zinc center to orient NAPE and orchestrate catalysis (Figures
S3C and S3D).
Bile Acids Regulate the Biosynthesis of FAEs
In addition to PE, the hydrophobic nook of NAPE-PLD contains
several molecules of bound DC, the natural bile acid that was
used to crystallize the protein (Figure 1). Two of these steroid
acids are contiguous to the tail end of the fatty acyl chains of
PE and interact with residues in the L1 loops of both enzyme sub-
units (Figure 2B). They form a primary micelle of bile acids (Diet-
schy, 1968), exposing their convex hydrophobic sides to the
membrane interface (Figure 2B). A tight binding pocket of the
protein structure holds these bile acids in place. The side chains
of residues W218 and R257, together with that of Y159 on the
opposite subunit, form four perfectly oriented H bonds with the
bile acid carboxylate group (Y159 OH–O3 DC = 2.3 A˚; R257
NE–O3 DC = 3.1 A˚; R257 NE–O4 DC = 2.7 A˚; W218 NE1–O4
DC = 3.2 A˚) (Figure 2B). Finally, a dense network of water-medi-
ated hydrogen bridges (through the hydroxyl groups in positionsts reserved
Figure 2. Interactions of NAPE-PLD with NAPE and Bile Acids
(A) Binding of NAPE to the active site of NAPE-PLD. A molecule of PE (carbon atoms in orange), which derives from the expression system used to produce the
enzyme, occupies the binding site reserved for the PE fragment of NAPE. Its phosphate group bidentately bridges the two Zn2+ of the metal center (Zn1 and Zn2).
Aspartate D284 bridges the two metal ions, while three histidine residues (H185, H187, and H253) fill the coordination sphere of Zn1, and residues D189, H190,
and H343 fill the coordination sphere of Zn2. A possible orientation of the N-acyl (oleoyl) substituent of NAPE is shown (carbons drawn in purple).
(B) Specific binding sites for steroid acids. Two pairs of DC molecules (carbons colored in green) bind to the L1 loops at the interface of NAPE-PLD with the
membrane. The central pair (carbons colored light green) forms a primary micelle of bile acids that exposes its hydrophobic convex side to the membrane
interface. These steroid acids expand the hydrophobic surface of the opposite subunit via their steroid A-rings (Figure S1) and interact directly with the fatty acyl
chains of PE. A network of H bonds (dotted lines) for the bile acid carboxylate groups is arranged by the side chains of Y188,W218, and R257, together with that of
Y159 of the opposite subunit. Two additional DC molecules (carbons colored dark green) form tight van der Waals contacts with the protein and expose their
hydrophilic concave sides. This pair contributes to orienting the steroid carboxylates of the central DC pair (carbons colored light green). Red spheres symbolize
water molecules involved in hydrogen bonding. Asterisks indicate residues and loops of the opposite dimer subunit.[3] and [12] of the steroid ring [Figure S1B]) reinforces the stability
of the micelle and its binding to NAPE-PLD (Figure 2B). The spe-
cific and symmetric interactions between each bile acid mole-
cule and the residues R257 and Y159 of both subunits indicate
that, upon binding, the bile acid micelle might stabilize the
conformation of both the loops L3 and L1 (Figure 2B), which
have a critical role in protein dimerization (Figures 1, 2, and
S1C). A second pair of DC molecules forms tight van der Waals
contacts with helix a3 of the same subunit, and with residue
M160 of the opposite subunit (3.6 A˚ close to the side chains
of W218, C222, and M160) (Figure 2B). Together, the four bile
acid molecules create an L1-bound symmetric lipidic substruc-
ture at the interface of NAPE-PLD with the membrane (Figures
2B and S1B), which is in a position to influence dimer assembly
and admission of NAPE into the active site.
Consistent with this hypothesis, the NAPE-PLD mutant
Q158S/Y159S, which cannot form stable dimers (Figure S3),
has a substantially lower melting temperature (Tm = 70
C) than
wild-type NAPE-PLD (Tm = 77
C) (Figure 3A). Furthermore, the
R257A mutant, which lacks a key residue implicated in DC bind-
ing (Figure 2B), has a Tm value of 71
C (Figure 3A). In addition to
stabilizing the NAPE-PLD dimer, DC regulates its activity.
Indeed, (1) the bile acid binds to NAPE-PLD with an affinity
(KD) of z38 mM (Figure 3B), comparable with KD values
measured at known bile acid receptors (e.g., FXR) (Makishima
et al., 1999); moreover, (2) this association is rapid and reversible
(ka = 9.93 10
3 M1 s1; kd = 0.44 s
1) (Figure 3C) and (3) results
in enzyme activation (EC50 = 186 mM) (Figure 3D). No such acti-
vation is seen with mutants that are unable to bind DC (mutantStructure 23,R257A) or form stable homodimers (mutant Q158S/Y159S) (Fig-
ure 3E). DC inhibits the detergent-stimulated activity of NAPE-
PLD (Triton X-100, 0.1%) with an IC50 of 8.8 mM (Figure 3F), a
concentration that might be reached in vivo (Dietschy, 1968),
suggesting a concentration-dependent bimodal regulation of
the enzyme. These results indicate that the bile acid DC selec-
tively binds to NAPE-PLD at micromolar concentrations and,
by doing so, it promotes protein dimer formation and enzyme
activity (Figure 3G). Overall, our findings suggest that the interac-
tion between NAPE-PLD and natural bile acids might have
potential biological relevance.
DISCUSSION
The crystal structure of human NAPE-PLD reveals how this
enzyme has adapted to perform three key processes needed
to initiate FAE signaling in cells. First, an extended lipid-binding
surface spanning the NAPE-PLD dimer (unprecedented in the
MbL superfamily) allows the enzyme to associate with mem-
branes (Figure 1). Second, a hydrophobic nook facing the lipid
bilayer (Figure 1) provides a recognition filter for NAPEs as a
glycerophospholipid class, while simultaneously accommoda-
ting different N-acyl substituents (Figure 2B). The enzyme has
a positively charged zinc center that overlooks the membrane,
which provides an attraction point for anionic NAPEs and helps
coordinate their hydrolysis (Figures S3C and S3D). Finally,
specific pockets within this cavity tightly bind four bile acid
molecules (Figure 2B), creating a unique protein-lipid molecular
architecture that is able to initiate the biosynthesis of bioactive598–604, March 3, 2015 ª2015 Elsevier Ltd All rights reserved 601
Figure 3. Bile Acids Regulate Dimer Formation and Catalytic Activity
(A) Representative fluorescence thermal shift profiles for the stabilization of the NAPE-PLD dimer in the presence of DC (0.2% w/v). The analysis yields a melting
temperature Tm = 77
C for the wild-type enzyme, and Tm = 71C and 70C for the mutants R257A and Q157S/Y158S, respectively (values are means for five
replicates).
(B) Binding thermodynamics profile for the titration of DC against NAPE-PLD obtained by isothermal titration calorimetry at 25C. Each peak corresponds to one
injection of DC (top panel, raw titration data; bottom panel, integration of the data, corrected for heat of dilution). Microcalorimetric analysis yields a KD = 38.5
(± 0.8) mM, DH = 1.2 (± 0.2) kcal/mol, and TDS = 4.9 (± 0.3) kcal/mol (errors quoted the SD of n = 3 experiments).
(C) Profiles of the binding kinetics for DC on immobilized NAPE-PLD obtained at 25C by surface plasmon resonance with FastStep injections. Analysis (of n = 3
replicates) yields a KD = 44(2) mM and dissociation constant kd = 0.44(3) s
1. RU, resonance units.
(legend continued on next page)
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lipid amides (Figure 3G). In this process, the steroid acids form
hydrogen bonds with residues of the L1 and L3 loops (Figure 2B),
contributing to both stabilizing the functional dimer assembly
of NAPE-PLD and shaping the enzyme hydrophobic nook (Fig-
ures 1 and 3G).
The primary physiological role of bile acids is the emulsifica-
tion and absorption of dietary fat in the small intestine. In mam-
mals, they also serve, however, important signaling functions in
cholesterol and glucose homeostasis by activating G protein-
coupled membrane receptors (e.g., TGR5) (Thomas et al.,
2008, 2009) and nuclear receptors (e.g., FXR) (Parks et al.,
1999; Mi et al., 2003). Our findings show that NAPE-PLD is a
novel cellular target of bile acids and that this enzyme might
orchestrate crosstalk between bile acids and lipid amide signals.
The interaction of bile acids with NAPE-PLD is likely to be func-
tionally important in the gut, where they might regulate mobiliza-
tion of oleylethanolamide, a FAE that promotes satiety and lipid
absorption. In addition, bile acids have been identified in the
brain (Ogundare et al., 2010), where they might contribute to
the production of FAEs, including the endocannabinoid ananda-
mide. Irrespective of these possible physiological roles, the bile
acid binding elements in NAPE-PLD offers targets for the design
of small-molecule modulators with potential applications in
inflammation, obesity, and cancer (Hotamisligil, 2006).
EXPERIMENTAL PROCEDURES
Plasmid Constructs and Mutagenesis
cDNA from a whole human Brain Library (Clontech) was used to amplify the
NAPE-PLD cDNA using conventional PCR methodologies. The region encod-
ing a truncated protein form (D47) from amino acid D47 to F393 was amplified
and inserted into the expression vector pMAL (NEB). The QuickChange site-
directed mutagenesis kit (Agilent) was used to introduce the Q158S/Y159S
or R257A mutations in pMAL (New England Biolabs) harboring the NAPE-
PLD sequence as template. All the constructs were sequenced and validated.
The resulting vector harboring the full-length gene was transformed into E. coli
RosettagamiB (DE3) pLysS cells (Novagen) to produce the encoded recombi-
nant protein with an N terminus maltose binding protein (MBP) tag and a
C terminus hexahistidine tag. For the expression of the protein in HEK293T
cells, the coding sequences of the full-length or D47 NAPE-PLD were inserted
into pcDNA 3.1 (Life Technologies).
Crystallization and Structure Determination
Protein samples from pLysS cells were purified by affinity chromatography
and, after MBP-tag cleavage, by size exclusion chromatography (16/600
200 pg column, GE Healthcare, elution buffer 20 mM HEPES [pH 7.8],
200 mM NaCl, in the absence or presence of DC). NAPE-PLD (0.09% DC)
was crystallized at 22C by vapor diffusion, using a buffer of 0.9 M LiSO4
and 0.1 M HEPES (pH 7.8). The phase problem was solved using a selenome-
thionine-substituted crystal and SAD data. Details of data collection and final
refinement statistics are reported in Table 1. Full methods are described in the
Supplemental Experimental Procedures and include details for protein expres-(D) Concentration-dependent activation of NAPE-PLD by DC. The activity of pu
detergents, using a liquid chromatography/mass spectrometry-based assay.
(E) In the absence of synthetic detergent, DC stimulates the activity of wild-type
NAPE-PLD mutants R257A and Q158S/Y159S. Enzyme activity was measured u
(F) In the presence of Triton X-100 (0.1%), DC inhibits the activity of wild-type e
Experimental Procedures). Results are expressed as means ( SEM (n = 6–9). *p
(G) Hypothetical mechanism of NAPE-PLD activation. According to this model,
inactive NAPE-PLD subunits (gray) into an active dimer. The resulting lipid-pro
positively charged binuclear zinc center (cyan) coordinates anionic NAPEs, gener
bioactive FAEs along with PA. A diversity of bioactive FAEs can be generated si
Structure 23,sion and purification, structure determination, bile acid binding thermody-
namics and kinetics, enzyme activity assays, and cryoimmunoelectron micro-
scopy analyses.
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